If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksK3C.L Regulatory News (K3C)

  • There is currently no data for K3C

Director/PDMR Shareholding

10 Mar 2020 14:00

RNS Number : 6273F
K3 Capital Group PLC
10 March 2020
 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

K3 CAPITAL GROUP PLC

("K3", the "Company" and including its subsidiaries, the "Group")

 

Director/PDMR Dealing

 

K3 Capital Group plc, a leading business and company sales specialist in the UK, announces that Ian Mattioli, Non-Executive Chairman of the Company, has today purchased 8,522 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 179 pence per Ordinary Share (the "Purchase").

 

Following the Purchase, Ian Mattioli, together with his connected persons, has a total interest over 683,794 Ordinary Shares, representing 1.62 per cent. of the Company's issued share capital.

 

-ENDS-

 

For further information please contact:

K3 Capital Group plc

Tel: c/o finnCap 020 7220 0500

John Rigby, Chief Executive Officer

www.k3capitalgroupplc.com

Andrew Melbourne, Chief Financial Officer

 

 

 

finnCap Ltd (Nominated Adviser and Sole Broker)

Tel: 020 7220 0500

Jonny Franklin-Adams, Anthony Adams (Corporate Finance)

Tim Redfern, Richard Chambers (Corporate Broking)

 

 

 

 

About K3 Capital

K3 Capital Group plc is a leading business sales and brokerage firm headquartered in Bolton with operations throughout the UK. It acts for vendors of businesses from c. £50,000 to c. £200 million through its three trading subsidiaries Knightsbridge, KBS Corporate, and KBS Corporate Finance. K3, through its trading subsidiaries, has received a number of adviser awards, most recently achieving the number 1 position in the 2019 Refinitiv Mid-Market M&A Review.

 

K3 Capital operates a disruptive business model with a direct marketing approach to client acquisition, using incentivised and experienced salespeople rather than advisory teams, while its highly visible online presence and proprietary online business valuation portal generates further leads. This innovative model, combined with a continuing strategy towards targeting higher value clients, are key drivers for growth and profitability.

 

The Group also offers all clients fully contingent and inclusive legal fees through its partner relationships with local and national law firms.

 

K3 Capital Group trades on the London Stock Exchange (AIM: K3C.L), having listed on 11 April 2017. Please visit www.k3capitalgroupplc.com for more information.

 

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Ian Mattioli - Non-Executive Chairman

2.

Reason for the notification

a)

Position/status:

Director

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

K3 Capital Group plc

b)

LEI:

21380043EWYIWISOAN87

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 penny per share

GB00BF1HPD20

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

£1.79

8,522

d)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

Value

£1.79

8,522

£15,254.38

e)

Date of the transaction:

10/03/2020

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBXGDXRGBDGGG
Date   Source Headline
28th Mar 20227:00 amRNSChange of Adviser
7th Mar 20222:10 pmRNSDirector/PDMR Shareholding
1st Mar 20227:00 amRNSAcquisition of JE Consulting
22nd Feb 20225:28 pmRNSIssue of Equity
7th Feb 20227:00 amRNSHalf-year Report
27th Jan 20227:00 amRNSNotice of Results and Investor Presentation
13th Dec 20217:00 amRNSTrading Update
7th Dec 202110:21 amRNSDirector/PDMR Shareholding
6th Dec 202111:15 amRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSDirector/PDMR Shareholding
25th Nov 202112:00 pmRNSResult of AGM
23rd Nov 20217:00 amRNSK3 to present at Mello
2nd Nov 202111:42 amRNSIssue of Equity
1st Nov 20212:05 pmRNSNotice of AGM & Dividend Timetable
1st Nov 20217:00 amRNSFinal Results and Notice of AGM
19th Oct 20217:00 amRNSInvestor Presentation
15th Oct 20217:00 amRNSNotice of Results
7th Sep 20214:17 pmRNSHolding(s) in Company
1st Sep 20217:00 amRNSIssue of Equity
7th Jul 202110:55 amRNSResult of Fundraising
7th Jul 20217:00 amRNSProposed Acquisitions and Placing to Raise £10m
21st Jun 202110:57 amRNSIssue of Equity
15th Jun 20217:00 amRNSTrading Update
24th May 20217:00 amRNSMaiden Debt Facility
5th May 20218:30 amRNSIssue of Equity
16th Apr 20217:00 amRNSIssue of Equity
14th Apr 20217:00 amRNSTrading Update
7th Apr 20214:04 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSTotal Voting Rights
31st Mar 20218:00 amRNSDirector/PDMR Shareholding
17th Mar 20217:00 amRNSDirector/PDMR Shareholding & Exercise of Options
4th Mar 20217:00 amRNSTrading Update
16th Feb 20213:15 pmRNSHolding(s) in Company
16th Feb 20217:00 amRNSHalf-year Report
3rd Feb 20217:00 amRNSNotice of Results and Investor Presentation
15th Jan 202112:00 pmRNSDirector/PDMR Shareholding
15th Dec 20209:05 amRNSSecond Price Monitoring Extn
15th Dec 20209:00 amRNSPrice Monitoring Extension
15th Dec 20207:00 amRNSAppointment of Joint Broker
15th Dec 20207:00 amRNSTrading Update
30th Nov 20207:00 amRNSJoint Venture Agreement
17th Nov 20207:00 amRNSAward of Growth Shares
13th Nov 20209:05 amRNSSecond Price Monitoring Extn
13th Nov 20209:00 amRNSPrice Monitoring Extension
9th Nov 20207:00 amRNSCompletion of Integration Plan
3rd Nov 20202:00 pmRNSLaunch of 2020 SAYE Scheme
16th Oct 202011:30 amRNSResult of AGM
7th Oct 202012:30 pmRNSStatement re change of AGM arrangements
23rd Sep 20201:12 pmRNSDirector/PDMR Shareholding
22nd Sep 20207:00 amRNSFinal Results and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.